Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT01998971
Title A Study of JNJ-54767414 (HuMax CD38) (Anti-CD38 Monoclonal Antibody) in Combination With Backbone Treatments for the Treatment of Patients With Multiple Myeloma
Recruitment Completed
Gender both
Phase Phase I
Variant Requirements No
Sponsors Janssen Research & Development, LLC
Indications
Therapies
Age Groups: adult
Covered Countries USA | FRA | ESP

Facility Status City State Zip Country Details
Duarte California United States Details
Atlanta Georgia United States Details
Chicago Illinois United States Details
Indianapolis Indiana United States Details
Boston Massachusetts United States Details
New York New York United States Details
Rochester New York United States Details
Charlotte North Carolina United States Details
Philadelphia Pennsylvania United States Details
Dallas Texas United States Details
Lille Cedex France Details
Nantes France Details
Paris France Details
Pessac France Details
Toulouse cedex 9 France Details
Tours France Details
Badalona Spain Details
Barcelona Spain Details
Madrid Spain Details
Pamplona Spain Details
Salamanca Spain Details
Valencia Spain Details
*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field